ABSTRACT
During infections, the host redistributes iron in order to starve pathogens from this nutrient. Several proteins are involved in iron absorption, transport, and storage. Ferritin is the most important iron storage protein. It is composed of variable proportions of two peptides, the L- and H-ferritins (FTL and FTH). We previously showed that macrophages increase their expression of FTH1 when they are infected in vitro with Mycobacterium avium, without a significant increase in FTL. In this work, we investigated the role of macrophage FTH1 in M. avium infection in vivo. We found that mice deficient in FTH1 in myeloid cells are more resistant to M. avium infection, presenting lower bacterial loads and lower levels of proinflammatory cytokines than wild-type littermates, due to the lower levels of available iron in the tissues. Importantly, we also found that FTH1 produced by myeloid cells in response to infection may be found in circulation and that it plays a key role in iron redistribution. Specifically, in the absence of FTH1 in myeloid cells, increased expression of ferroportin is observed in liver granulomas and increased iron accumulation occurs in hepatocytes. These results highlight the importance of FTH1 expression in myeloid cells for iron redistribution during infection.
Subject(s)
Blood Circulation , Ferritins/blood , Iron/metabolism , Liver/metabolism , Mycobacterium Infections/blood , Myeloid Cells/metabolism , Animals , Cation Transport Proteins/metabolism , Ferritins/deficiency , Gene Expression Regulation , Inflammation/pathology , Iron Deficiencies/blood , Iron Deficiencies/metabolism , Iron Overload/blood , Iron Overload/metabolism , Mice , Mycobacterium Infections/genetics , Mycobacterium avium/growth & development , Mycobacterium avium/physiologyABSTRACT
Anemia is a frequent and challenging complication of mycobacterial infections. We used a model of disseminated Mycobacterium avium infection in mice to investigate the mechanisms of mycobacteria-induced anemia. We found increased formation of RBC in the bone marrow and spleen of infected mice. Infection induced reticulocytosis and the premature egress of immature progenitors to the systemic circulation in an IFN-γ (IFNG)-dependent way. The newly formed RBC had reduced CD47 surface expression and a reduced life span and were phagocytosed in the liver of infected mice, increasing iron recycling in this organ. The increased engulfment and degradation of RBC was independent of IFNG sensing by macrophages. Together, our findings demonstrate that mycobacterial infection alters the formation of erythrocytes, leading to their accelerated removal from circulation and hemolytic anemia. This comprehensive elucidation of the mechanisms underlying mycobacteria-induced anemia has important implications for its efficient clinical management.
Subject(s)
Anemia/etiology , Erythrocytes/physiology , Interferon-gamma/physiology , Mycobacterium Infections/complications , Animals , Bone Marrow Cells/cytology , CD47 Antigen/analysis , Cell Differentiation , Erythropoiesis , Hepcidins/physiology , Mice , Mice, Inbred C57BL , Mycobacterium Infections/blood , PhagocytosisABSTRACT
Mycobacteriosis is an emerging zoonotic disease of domestic cats and timely, accurate diagnosis is currently challenging. To identify differential cytokine/chemokine concentrations in serum/plasma of cats, which could be diagnostic biomarkers of infection we analysed plasma/serum from 116 mycobacteria-infected cats, 16 healthy controls and six cats hospitalised for unrelated reasons was analysed using the Milliplex MAP Feline Cytokine Magnetic Bead multiplex assay. Three cytokines; sFAS, IL-13 and IL-4 were reduced while seven; GM-CSF, IL-2, PDGF-BB, IL-8, KC, RANTES and TNF-α were elevated in mycobacteria-infected cats compared to healthy controls. However, IL-8 and KC concentrations were not significantly different from cats hospitalised for other reasons. Elevations in TNF-α and PDGF-BB may have potential to identify M. bovis and M. microti infected cats specifically while GM-CSF, IL-2 and FLT3L were increased in MTBC infected cats. This study demonstrates potential use of feline tuberculosis as a spontaneously occurring model of this significant human disease. Cytokine profiling has clear diagnostic potential for mycobacteriosis of cats and could be used discriminate tuberculous from non-tuberculous disease to rapidly inform on zoonotic risk. Future work should focus on the in-field utility of these findings to establish diagnostic sensitivity and specificity of these markers.
Subject(s)
Biomarkers/blood , Cat Diseases/diagnosis , Chemokines/blood , Cytokines/blood , Mycobacterium Infections/veterinary , Mycobacterium/isolation & purification , Animals , Cat Diseases/blood , Cat Diseases/microbiology , Cats , Mycobacterium Infections/blood , Mycobacterium Infections/diagnosis , Mycobacterium Infections/microbiologyABSTRACT
Four patients with adult-onset, disseminated mycobacterial infection had 5' UTR mutations in IKBKG without clear physical stigmata of NEMO deficiency. These mutations caused decreased levels of NEMO protein and Toll-like receptor driven cytokine production. Three patients died from disseminated disease. These mutations may be missed by whole exome sequencing.
Subject(s)
Ectodermal Dysplasia/complications , Genetic Diseases, X-Linked/complications , I-kappa B Kinase/genetics , Immunologic Deficiency Syndromes/complications , Mycobacterium Infections/genetics , RNA Splice Sites , Adult , Ectodermal Dysplasia/microbiology , Genetic Diseases, X-Linked/microbiology , Humans , Immunologic Deficiency Syndromes/microbiology , Male , Mutation , Mycobacterium Infections/blood , Mycobacterium Infections/mortality , Primary Immunodeficiency Diseases , Signal Transduction , Skin/microbiology , Skin/pathologyABSTRACT
A previously undescribed, rapidly growing, scotochromogenic species of the genus Mycobacterium (represented by strains PB739T and GK) was isolated from two clinical sources - the sputum of a 76-year-old patient with severe chronic obstructive pulmonary disease, history of tuberculosis exposure and Mycobacterium avium complex isolated years prior; and the blood of a 15-year-old male with B-cell acute lymphoblastic leukaemia status post bone marrow transplant. The isolates grew as dark orange colonies at 25-37 °C after 5 days, sharing features in common with other closely related species. Analysis of the complete 16S rRNA gene sequence (1492 bp) of strain PB739T demonstrated that the isolate shared 98.8â% relatedness with Mycobacterium wolinskyi. Partial 429 bp hsp65 and 744 bp rpoB region V sequence analyses revealed that the sequences of the novel isolate shared 94.8 and 92.1â% similarity with those of Mycobacterium neoaurum and Mycobacterium aurum, respectively. Biochemical profiling, antimicrobial susceptibility testing, HPLC/gas-liquid chromatography analyses and multilocus sequence typing support the taxonomic status of these isolates (PB739T and GK) as representatives of a novel species. Both isolates were susceptible to the Clinical and Laboratory Standards Institute recommended antimicrobials for susceptibility testing of rapidly growing mycobacteria including amikacin, ciprofloxacin, moxifloxacin, doxycycline/minocycline, imipenem, linezolid, clarithromycin and trimethropin/sulfamethoxazole. Both isolates PB739T and GK showed intermediate susceptibility to cefoxitin. We propose the name Mycobacterium grossiae sp. nov. for this novel species and have deposited the type strain in the DSMZ and CIP culture collections. The type strain is PB739T (=DSM 104744T=CIP 111318T).
Subject(s)
Mycobacterium Infections/microbiology , Mycobacterium/classification , Phylogeny , Adolescent , Aged , Bacterial Typing Techniques , Blood Culture , DNA, Bacterial/genetics , Humans , Male , Multilocus Sequence Typing , Mycobacterium/genetics , Mycobacterium/isolation & purification , Mycobacterium Infections/blood , Pigmentation , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , Sputum/microbiologyABSTRACT
We evaluated commercially available bovine enzyme linked immunosorbent assays (ELISA) and a human IP-10 ELISA to measure IP-10, MIG, MCP-1, MCP-2, MCP-3 and IL1-RA in buffalo plasma in order to identify sensitive markers of the immune response to Mycobacterium bovis-specific peptides. Additionally, we found that all coding mRNA sequences of these cytokines showed very high homology with their homologues in domestic cattle (97-99%) as did the derived amino acid sequences (97-99%). This high sequence homology between cattle and buffaloes supports the use of bovine ELISAs for the detection these cytokines in buffaloes. MCP-1 concentration showed a positive correlation with that of IFN-γ (p=0.0077) and appears to occur in far greater abundance in buffaloes when compared to humans. Using a bovine IP-10 ELISA, levels of this cytokine were found to be significantly increased in antigen-stimulated blood samples from M. bovis test positive buffaloes (p<0.0001) and IP-10 was detected in far greater abundance than IFN-γ. Measurement of IP-10 with this ELISA may prove to be a sensitive marker of M. bovis infection in African buffaloes.
Subject(s)
Biomarkers/blood , Buffaloes/microbiology , Enzyme-Linked Immunosorbent Assay/veterinary , Immunity, Cellular/immunology , Mycobacterium Infections/veterinary , Mycobacterium bovis/immunology , Animals , Buffaloes/blood , Buffaloes/immunology , Cattle , Chemokine CXCL10/blood , Chemokine CXCL9/blood , Enzyme-Linked Immunosorbent Assay/methods , Interleukin 1 Receptor Antagonist Protein/blood , Monocyte Chemoattractant Proteins/blood , Mycobacterium Infections/blood , Mycobacterium Infections/immunology , Statistics, NonparametricABSTRACT
Subjects exposed to non-tuberculous mycobacterium (NTM) species do not always develop an active disease, which likely reflects underlying host susceptibility factors. Recent reports have shown that anti interferon gamma (IFN-γ) neutralizing autoantibodies (IFN-γ Ab) are associated with the development of disseminated NTM in patients without known evidence of immunodeficiency. The purpose of this study is to establish the screening method if subjects have IFN-γ Ab. Whole blood was obtained from patients with disseminated NTM, those with pulmonary NTM, and healthy controls. The neutralizing capacity to IFN-γ activity was assessed as an inhibition of Signal Transducer and Activation of Transcription 1 (STAT-1) phosphorylation in leukocyte after stimulation with exogenous IFN-γ by flow cytometer. The strength of phosphorylation was described as STAT1 phosphorylation index. Antigen capture assay was performed to measure the relative titer of Immunoglobulin-G fraction of IFN-γ Ab. STAT1 phosphorylation by IFN-γ was significantly inhibited in the leukocytes from patients with disseminated NTM compared to that in healthy subjects, while this inhibition was not observed in patients with pulmonary NTM. All subjects with inhibited STAT1 phosphorylation had high titer of Immunoglobulin-G that reacted with IFN-γ in the antigen capture assay. The measurement of STAT1 phosphorylation index in whole blood leukocytes and antigen capture assay are simple and useful method for detection of anti-IFN-γ neutralizing autoantibodies, and is valuable in the pathophysiological diagnosis of disseminated NTM patients without obvious immunodeficiency.
Subject(s)
Antibodies, Neutralizing/immunology , Autoantibodies/immunology , Interferon-gamma/immunology , Mycobacterium Infections/immunology , Tuberculosis/immunology , Antibodies, Neutralizing/blood , Autoantibodies/blood , Biological Assay/methods , Humans , Immunoglobulin G/immunology , Leukocytes/immunology , Mycobacterium Infections/blood , Phosphorylation/immunology , STAT1 Transcription Factor/immunologyABSTRACT
Autoantibodies against cytokines, chemokines, and growth factors inhibit normal immunity and are implicated in inflammatory autoimmune disease and diseases of immune deficiency. In an effort to evaluate serum from autoimmune and immunodeficient patients for Abs against cytokines, chemokines, and growth factors in a high-throughput and unbiased manner, we constructed a multiplex protein microarray for detection of serum factor-binding Abs and used the microarray to detect autoantibody targets in SLE. We designed a nitrocellulose-surface microarray containing human cytokines, chemokines, and other circulating proteins and demonstrated that the array permitted specific detection of serum factor-binding probes. We used the arrays to detect previously described autoantibodies against cytokines in samples from individuals with autoimmune polyendocrine syndrome type 1 and chronic mycobacterial infection. Serum profiling from individuals with SLE revealed that among several targets, elevated IgG autoantibody reactivity to B cell-activating factor (BAFF) was associated with SLE compared with control samples. BAFF reactivity correlated with the severity of disease-associated features, including IFN-α-driven SLE pathology. Our results showed that serum factor protein microarrays facilitate detection of autoantibody reactivity to serum factors in human samples and that BAFF-reactive autoantibodies may be associated with an elevated inflammatory disease state within the spectrum of SLE.
Subject(s)
Autoantibodies/immunology , Autoantigens/immunology , B-Cell Activating Factor/immunology , Immunoglobulin G/immunology , Lupus Erythematosus, Systemic/immunology , Protein Array Analysis , Animals , Antibody Specificity , Autoantibodies/blood , Cytokines/immunology , Humans , Immunoglobulin G/blood , Inflammation , Interferon-alpha/immunology , Mice , Mycobacterium Infections/blood , Mycobacterium Infections/immunology , Polyendocrinopathies, Autoimmune/blood , Polyendocrinopathies, Autoimmune/immunology , Recombinant Proteins/immunologyABSTRACT
Trehalose 6,6'-dimycolate (TDM) is a major glycolipid of the cell wall of mycobacteria with remarkable adjuvant functions. To avoid detection by the host innate immune system, invading mycobacteria down-regulate the expression of TDM by utilizing host-derived glucose as a competitive substrate for their mycolyltransferases; however, this enzymatic reaction results in the concomitant biosynthesis of glucose monomycolate (GMM) which is recognized by the acquired immune system. GMM-specific, CD1-restricted T cell responses have been detected in the peripheral blood of infected human subjects and monkeys as well as in secondary lymphoid organs of small animals, such as guinea pigs and human CD1-transgenic mice. Nevertheless, it remains to be determined how tissues respond at the site where GMM is produced. Here we found that rhesus macaques vaccinated with Mycobacterium bovis bacillus Calmette-Guerin mounted a chemokine response in GMM-challenged skin that was favorable for recruiting T helper (Th)1 T cells. Indeed, the expression of interferon-γ, but not Th2 or Th17 cytokines, was prominent in the GMM-injected tissue. The GMM-elicited tissue response was also associated with the expression of monocyte/macrophage-attracting CC chemokines, such as CCL2, CCL4 and CCL8. Furthermore, the skin response to GMM involved the up-regulated expression of granulysin and perforin. Given that GMM is produced primarily by pathogenic mycobacteria proliferating within the host, the Th1-skewed tissue response to GMM may function efficiently at the site of infection.
Subject(s)
Glycolipids/immunology , Macaca mulatta/immunology , Macaca mulatta/microbiology , Mycobacterium Infections/microbiology , Mycobacterium/immunology , Organ Specificity/immunology , Th1 Cells/immunology , Animals , Chemokines/blood , Humans , Interferon-gamma/metabolism , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/microbiology , Macaca mulatta/blood , Macrophages/immunology , Mice , Models, Biological , Mycobacterium Infections/blood , Mycobacterium Infections/immunology , Skin/immunology , Skin/microbiology , Skin/pathologyABSTRACT
RATIONALE: Inadequacy of T-cell responses may result in the development of tuberculosis (TB). Myeloid-derived suppressor cells (MDSCs) have been described as suppressors of T-cell function in cancer biology and recently in several infectious diseases. OBJECTIVES: To explore the presence and role of MDSCs in TB. METHODS: We analyzed surface markers of MDSCs in peripheral blood and at the site of disease in TB cases and in patients with lung cancer, and in peripheral blood of asymptomatic tuberculin skin test-positive individuals with recent (household) or remote exposure to Mycobacterium tuberculosis (M.tb) and in uninfected healthy control subjects. To evaluate the suppressive capacity of MDSCs, cells of household contacts infected with M.tb and TB cases were isolated and cocultured with CD3(+) T cells. MEASUREMENTS AND MAIN RESULTS: Our results demonstrate an increased presence of MDSCs after recent M.tb infection and disease. We confirm their suppression of CD4(+) T-cell function, including reduced cytokine responses and inhibition of CD4(+) T-cell proliferation. Only MDSCs from TB cases reduced T-cell activation, altered T-cell trafficking, and suppressed CD8(+) T-cell functions. M.tb-expanded MDSCs were associated with significantly higher IL-1ß, IL-6, IL-8, granulocyte colony-stimulating factor, and monocyte chemotactic protein-1, and reduced granulocyte-macrophage colony-stimulating factor and macrophage inflammatory protein-1 beta levels in coculture. CONCLUSIONS: These data reveal that innate MDSCs are induced not only during active TB at similar levels as found in cancer, but also in healthy individuals after recent exposure to M.tb. These cells diminish protective T-cell responses and may contribute to the inability of hosts to eradicate the infection and add to the subsequent development of TB disease.
Subject(s)
Mycobacterium Infections/immunology , Mycobacterium tuberculosis/immunology , Myeloid Cells/immunology , T-Lymphocytes/immunology , Tuberculosis/immunology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cytokines/blood , Cytokines/immunology , Flow Cytometry/methods , Granulocyte Colony-Stimulating Factor/immunology , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Humans , Interleukin-1beta/immunology , Interleukin-6/immunology , Interleukin-8/immunology , Lung Neoplasms/blood , Mycobacterium Infections/blood , Tuberculin Test/methods , Tuberculosis/bloodABSTRACT
ISG15 is an interferon (IFN)-α/ß-inducible, ubiquitin-like intracellular protein. Its conjugation to various proteins (ISGylation) contributes to antiviral immunity in mice. Here, we describe human patients with inherited ISG15 deficiency and mycobacterial, but not viral, diseases. The lack of intracellular ISG15 production and protein ISGylation was not associated with cellular susceptibility to any viruses that we tested, consistent with the lack of viral diseases in these patients. By contrast, the lack of mycobacterium-induced ISG15 secretion by leukocytes-granulocyte, in particular-reduced the production of IFN-γ by lymphocytes, including natural killer cells, probably accounting for the enhanced susceptibility to mycobacterial disease. This experiment of nature shows that human ISGylation is largely redundant for antiviral immunity, but that ISG15 plays an essential role as an IFN-γ-inducing secreted molecule for optimal antimycobacterial immunity.
Subject(s)
Cytokines/immunology , Interferon-gamma/immunology , Mycobacterium Infections/immunology , Ubiquitins/immunology , Virus Diseases/immunology , Animals , Antibodies, Viral/blood , Cytokines/genetics , Female , Granulocytes/immunology , Humans , Immunity , Interleukin-12/immunology , Killer Cells, Natural/immunology , Male , Mice , Mycobacterium Infections/blood , Mycobacterium Infections/genetics , Pedigree , T-Lymphocytes/immunology , Ubiquitins/genetics , Virus Diseases/bloodABSTRACT
Vitamin D insufficiency is regularly observed in human patients with tuberculosis but it is unknown if spontaneous mycobacteria infections in other species are associated with suboptimal vitamin D status. Serum 25 hydroxyvitamin D (25(OH)D) concentrations were significantly lower in cats with mycobacteriosis than in healthy cats (P < 0.001).
Subject(s)
Cat Diseases/blood , Mycobacterium Infections/veterinary , Vitamin D/analogs & derivatives , Animals , Cats , Mycobacterium Infections/blood , Vitamin D/bloodABSTRACT
Innate cells are essential for host defense against invading pathogens, and the induction and direction of adaptive immune responses to infection. We developed and optimized a flow cytometric assay that allows measurement of intracellular cytokine expression by monocytes, dendritic cells (DC) and granulocytes, as well as cellular uptake of green-fluorescent protein (GFP)-expressing mycobacteria, in very small volumes of peripheral blood. We show that innate cell stimulation resulted in increased granularity of monocytes and mDC and decreased granulocyte granularity that precluded flow cytometric discernment of granulocytes from monocytes and myeloid DC by forward and side scatter gating. Anti-CD66a/c/e antibody staining allowed reliable identification and exclusion of granulocytes for subsequent delineation of monocytes and myeloid DC. Intracellular cytokine expression by granulocytes, monocytes and mDC was remarkably sensitive to the dose of mycobacterial inoculum. Moreover, activation of monocytes and mDC with live BCG reduced expression levels of CD14 and CD11c, respectively, necessitating optimization of staining conditions to reliably measure these lineage markers. Finally, we characterized expression of IL-12/23p40, TNF-α, IL-6, and IL-10, by GFP(+) and GFP(-) monocytes and mDC from 25 healthy adults. This assay may be applied to the study of innate cell responses to any GFP-expressing pathogen, and can be performed on blood volumes as low as 200 µL per condition, making the assay particularly suitable for pediatric studies.
Subject(s)
Cytokines/immunology , Flow Cytometry/methods , Mycobacterium Infections/immunology , Mycobacterium/immunology , Adolescent , Adult , Cytokines/blood , Dendritic Cells/immunology , Dendritic Cells/microbiology , Granulocytes/immunology , Granulocytes/microbiology , Green Fluorescent Proteins/analysis , Green Fluorescent Proteins/chemistry , Humans , Immunity, Innate/immunology , Middle Aged , Monocytes/immunology , Monocytes/microbiology , Mycobacterium Infections/blood , Mycobacterium Infections/microbiology , Mycobacterium Infections/prevention & control , Young AdultABSTRACT
To demonstrate the usefulness of enzyme-linked immunosorbent assay for serodiagnosis of mycobacterioses due to environmental mycobacteria we utilized a panel of glycolipid antigens selective for Mycobacterium avium-intracellulare, Mycobacterium kansasii, Mycobacterium xenopi, Mycobacterium scrofulaceum and Mycobacterium gordonae. The levels of circulating antibodies were determined against the environmental mycobacteria, and Mycobacterium tuberculosis in human immunodeficiency virus-negative and -positive patient sera. The method used immunomagnetic separation of the antigens, with covalent immobilization of antibodies to superparamagnetic amine and carboxyl terminated particles in solutions of the specific antigens. Enzyme-linked immunosorbent assay was performed on 195 patient sera: 34 with infections due to environmental mycobacteria, 114 with tuberculosis, 47 with other respiratory diseases. There were 46 human immunodeficiency virus-1 infected individuals. Among the 34 infections due to environmental mycobacteria, 9 patients were singularly infected with an environmental mycobacterium, and 25 co-infected with both M. tuberculosis and an environmental mycobacterium. Sensitivity, specificity and false positivity ranges were determined for each of the volunteer groups: tuberculosis positive, human immunodeficiency virus negative; tuberculosis positive, human immunodeficiency virus positive; those with infections due to individual environmental mycobacteria (such as M. scrofulaceum and M. kansasii); and those with other respiratory diseases. We demonstrate that such multiple assays, can be useful for the early diagnosis of diverse environmental mycobacterial infections to allow the start of treatment earlier than henceforth.
Subject(s)
Enzyme-Linked Immunosorbent Assay/methods , Mycobacterium Infections/blood , Mycobacterium Infections/diagnosis , Mycobacterium/isolation & purification , Serologic Tests/methods , Antibodies, Bacterial/blood , Antigen-Antibody Reactions , Antigens, Bacterial/immunology , Glycolipids/immunology , Humans , Magnetics , Mycobacterium/immunology , Mycobacterium Infections/immunologyABSTRACT
Wnt proteins are secreted, palmitoylated glycoproteins with multiple functions in cell proliferation and migration as well as tissue organization. They are best known for their role in embryonic development and tissue homeostasis. In the last years, Wnt signaling was also shown to be involved in the regulation of inflammatory processes: Wnt5a is induced in human macrophages in response to mycobacteria and conserved bacterial structures and contributes to the regulation of pro-inflammatory cytokines via its receptor Frizzled (Fzd) 5. Wnt5a is also induced in other infectious and inflammatory diseases such as tuberculosis, sepsis, psoriasis, rheumatoid arthritis and atherosclerosis. In contrast, Wnt3a, a ligand of Fzd1, is constitutively expressed by bronchial epithelial cells and mediates anti-inflammatory effects on mycobacteria-infected macrophages via the Wnt/beta-Catenin signaling pathway. This pathway suppresses the activity of GSK3beta, a well known regulator of NF-kappaB-dependent gene transcription. Here we review recent data on immunomodulatory activities of Wnt proteins. Additional experiments using exogenous Wnt homologs further support the notion that TLR/NF-kappaB and Wnt signaling are functionally interconnected.
Subject(s)
Macrophages/metabolism , Mycobacterium Infections/metabolism , Mycobacterium/metabolism , Wnt Proteins/metabolism , Animals , Humans , Macrophages/immunology , Mice , Mycobacterium Infections/blood , Mycobacterium Infections/immunology , Signal Transduction , Wnt Proteins/immunologyABSTRACT
BACKGROUND: Buruli Ulcer (BU) is a severe cutaneous and subcutaneous disease due to Mycobacterium ulcerans infection, mainly distributed in sub-Saharan Africa and tropical areas. The role of T helper (TH) cytokines in the development and clinical course of the disease has been previously studied by investigating the in vitro immune response of lymphocytes from affected patients and immunohistochemical analyses of bioptic samples. METHODS: TH cytokine levels (IFNγ, TNF-α, IL-2, IL-10, IL-4, IL-5, IL-17) were evaluated in serum of 34 Beninese subjects by cytofluorimetric and immunoenzymatic assays: 16 patients affected with active BU, 4 patients who had healed after specific therapy, and 14 matched controls. RESULTS: Levels of IFNγ were higher in patients with late BU (>2 months from onset) and healed patients than in controls, and in ulcerative than in pre-ulcerative patients. Analysis of 4 patients with "late" disease evaluated both at the beginning of antibiotic therapy and 6 months later showed that IFNγ levels were always lower in the second evaluation. By contrast, no differences were found in levels of the other cytokines. CONCLUSIONS: IFNγ production is low in early BU, and increases in late BU and healing, suggesting a role of this cytokine in infection clearance. Moreover, evaluation of IFNγ serum levels may be a useful tool to monitor the immune response during the BU course.
Subject(s)
Interferon-gamma/blood , Interleukins/blood , Mycobacterium Infections/blood , Mycobacterium ulcerans , Tumor Necrosis Factor-alpha/blood , Adolescent , Adult , Child , Female , Humans , Infant , Male , Statistics, Nonparametric , Young AdultABSTRACT
Mycobacterium spp. infection is an important health concern for Asian elephant (Elephas maximus) populations worldwide. The disease is of particular concern considering its potential to affect not only the individual animal but also herd and public health. Although elephant tuberculosis susceptibility is poorly understood, immune function alterations are central to disease pathogenesis in other species and probably affect outcome of mycobacterial infections in elephants. Measurement of immune mediator (cytokine) levels within blood samples can provide information regarding immune function that may elucidate disease susceptibility. For this study, mRNA levels of interleukin (IL)-2, IL-4, IL-10, and IL-12; interferon (IFN)-gamma; tumor necrosis factor (TNF)-alpha; and transforming growth factor (TGF)-beta were measured using elephant-specific, real-time reverse transcription-polymerase chain reaction (RT-PCR) assays in RNA-preserved whole blood samples from 106 Asian elephants, 15% of which were Mycobacterium tuberculosis complex seropositive. The Elephant TB STAT-PAK (Chembio Diagnostics, Inc., Medford, New York 11763, USA), a novel lateral flow antibody detection assay developed for specific use in elephants, was used to determine serologic status for the study. Seropositive animals had higher levels of TNF-alpha and lower levels of TGF-beta than seronegative animals; these differences between groups were statistically significant when levels were analyzed as categorical variables. Trends toward higher levels of IFN-gamma and IL-4 and slightly lower levels of IL-10 and IL-12 were noted in the seropositive group, although differences between groups were not statistically significant. Presence of other inflammatory conditions was found to be a significant confounding variable in the analysis of the relationship between tuberculosis status and TNF-alpha levels, necessitating its inclusion in statistical models. Age and sex were not found to significantly affect the relationship between tuberculosis status and any of the cytokines measured. Interleukin-2 levels were below the sensitivity of the real-time RT-PCR assay irrespective of tuberculosis status. These findings provide a foundation for future research into the immunopathogenesis of elephant tuberculosis.
Subject(s)
Cytokines/blood , Elephants , Mycobacterium Infections/veterinary , Mycobacterium/isolation & purification , Animals , Female , Gene Expression Regulation , Male , Mycobacterium Infections/blood , Polymerase Chain Reaction/veterinary , RNA, Messenger/blood , RNA, Messenger/genetics , RNA, Messenger/metabolismSubject(s)
Blood Group Antigens , Receptors, Complement 3b/blood , Blood Group Antigens/analysis , Blood Group Antigens/classification , Blood Group Antigens/genetics , Blood Group Antigens/immunology , Chromosomes, Human, Pair 1/genetics , Coombs Test , Ethnicity/genetics , Humans , Isoantibodies/immunology , Leishmaniasis/blood , Malaria, Falciparum/blood , Membrane Glycoproteins/blood , Membrane Glycoproteins/immunology , Mycobacterium Infections/blood , Polymorphism, Genetic , Receptors, Complement 3b/genetics , Receptors, Complement 3b/immunology , Rosette Formation , Saliva/chemistry , Sequence Deletion , Urine/chemistryABSTRACT
Bacille Calmette Guérin substrain Moreau Rio de Janeiro is an attenuated strain of Mycobacterium bovis that has been used extensively as an oral tuberculosis vaccine. We assessed its potential as a challenge model to study clinical and immunological events following repeated mycobacterial gut infection. Seven individuals received three oral challenges with approximately 10(7) viable bacilli. Clinical symptoms, T-cell responses and gene expression patterns in peripheral blood were monitored. Clinical symptoms were relatively mild and declined following each oral challenge. Delayed T-cell responses were observed, and limited differential gene expression detected by microarrays. Oral challenge with BCG Moreau Rio de Janeiro vaccine was immunogenic in healthy volunteers, limiting its potential to explore clinical innate immune responses, but with low reactogenicity.
Subject(s)
Immunity, Innate , Intestinal Diseases , Mycobacterium Infections , Mycobacterium bovis/immunology , T-Lymphocytes/immunology , Tuberculosis Vaccines/administration & dosage , Tuberculosis Vaccines/immunology , Adolescent , Adult , Female , Humans , Intestinal Diseases/blood , Intestinal Diseases/immunology , Intestinal Diseases/microbiology , Intestinal Diseases/therapy , Male , Middle Aged , Mycobacterium Infections/blood , Mycobacterium Infections/immunology , Mycobacterium Infections/microbiology , Mycobacterium Infections/therapy , T-Lymphocytes/metabolismABSTRACT
We identified 18 patients with the distinct clinical phenotype of susceptibility to disseminated nontuberculous mycobacterial infections, viral infections, especially with human papillomaviruses, and fungal infections, primarily histoplasmosis, and molds. This syndrome typically had its onset in adulthood (age range, 7-60 years; mean, 31.1 years; median, 32 years) and was characterized by profound circulating monocytopenia (mean, 13.3 cells/microL; median, 14.5 cells/microL), B lymphocytopenia (mean, 9.4 cells/microL; median, 4 cells/microL), and NK lymphocytopenia (mean, 16 cells/microL; median, 5.5 cells/microL). T lymphocytes were variably affected. Despite these peripheral cytopenias, all patients had macrophages and plasma cells at sites of inflammation and normal immunoglobulin levels. Ten of these patients developed 1 or more of the following malignancies: 9 myelodysplasia/leukemia, 1 vulvar carcinoma and metastatic melanoma, 1 cervical carcinoma, 1 Bowen disease of the vulva, and 1 multiple Epstein-Barr virus(+) leiomyosarcoma. Five patients developed pulmonary alveolar proteinosis without mutations in the granulocyte-macrophage colony-stimulating factor receptor or anti-granulocyte-macrophage colony-stimulating factor autoantibodies. Among these 18 patients, 5 families had 2 generations affected, suggesting autosomal dominant transmission as well as sporadic cases. This novel clinical syndrome links susceptibility to mycobacterial, viral, and fungal infections with malignancy and can be transmitted in an autosomal dominant pattern.